OTCMKTS:CPHRF

Cipher Pharmaceuticals - CPHRF Stock Forecast, Price & News

$2.56

0.00 (0.00%)

(As of 02/7/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.56
▼
$2.67
50-Day Range: $2.54
▼
$5.38
52-Week Range: $1.06
▼
$5.38

Volume: 2,483 shs
Average Volume: 7,068 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Headlines

Short Interest

About Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock

Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.

Receive CPHRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPHRF Stock News Headlines

January 31, 2023 | finance.yahoo.com

Cipher Pharmaceuticals (TSE:CPH) shareholders have earned a 51% CAGR over the last three years

January 13, 2023 | finanznachrichten.de

Cypher Core, Inc: CIPHER-CORE, Inc. President Addresses Company's Business Direction

February 7, 2023 | Wall Street Watch Dogs (Ad)

The #1 Energy Stock to Buy

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

November 11, 2022 | ca.finance.yahoo.com

Cipher Pharmaceuticals Inc. (CPHRF)

November 10, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share

August 24, 2022 | finance.yahoo.com

Investing in Cipher Pharmaceuticals (TSE:CPH) three years ago would have delivered you a 107% gain

August 12, 2022 | seekingalpha.com

Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call Transcript

August 11, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO

February 7, 2023 | Wall Street Watch Dogs (Ad)

The #1 Energy Stock to Buy

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

July 9, 2022 | theglobeandmail.com

Cipher Pharmaceuticals Inc stock boosted on Friday.

May 14, 2022 | seekingalpha.com

Cipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4M

March 24, 2022 | finance.yahoo.com

Is Now The Time To Put Cipher Pharmaceuticals (TSE:CPH) On Your Watchlist?

March 22, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study

March 18, 2022 | benzinga.com

MariMed Doubles Full Year Revenue And Adjusted EBITDA, Reports Q4 & Full Year Earnings

March 18, 2022 | msn.com

Marijuana Stock Movers For March 16, 2022

March 18, 2022 | benzinga.com

Researcher Who Discovered Cannabinoid Acids May Prevent COVID-19 Infection Launches His Own Company

March 13, 2022 | benzinga.com

Novamind Stock Slightly Up On Grants Restricted Share Units

March 11, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference Call

March 10, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun Pharmaceutical Industries Inc.

March 8, 2022 | benzinga.com

There's Never Been A Better Time To Be A Weed Edibles Chef

January 18, 2022 | benzinga.com

Interview With Julianne Keu, Psychedelic YouTuber

January 17, 2022 | benzinga.com

Psychedelics Can Change Your View On The Nature Of Reality

January 17, 2022 | finance.yahoo.com

Cipher Pharmaceuticals Inc. (TSE:CPH) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

January 16, 2022 | benzinga.com

Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner

December 21, 2021 | benzinga.com

Glass House Brands To Acquire California Cannabis Edibles Manufacturer For $25.6M

August 15, 2021 | finance.yahoo.com

Cipher Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

August 1, 2021 | benzinga.com

Australia Gets Psychedelics Research Institute With $29M In Funding From Undisclosed North American Company

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CPHRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPHRF Company Calendar

Last Earnings: 5/05/2016
Today: 2/07/2023
Next Earnings (Estimated): 3/15/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CPHRF
Previous Symbol: NASDAQ:CPHR
CUSIP: N/A
CIK: N/A
Web: www.cipherpharma.com
Phone: (905) 602-5840
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Craig Mull
Chairman & Chief Executive Officer

Bryan Jacobs
Chief Financial Officer

Diane Gajewczyk
Vice President-Scientific & Medical Affairs

James Bowen
Investor Relations Contact

Key Competitors

View All Competitors

CPHRF Stock - Frequently Asked Questions

How have CPHRF shares performed in 2023?: Cipher Pharmaceuticals' stock was trading at $2.7949 at the start of the year. Since then, CPHRF shares have decreased by 8.4% and is now trading at $2.56.
View the best growth stocks for 2023 here.
Are investors shorting Cipher Pharmaceuticals?: Cipher Pharmaceuticals saw a decrease in short interest during the month of December. As of December 30th, there was short interest totaling 1,600 shares, a decrease of 33.3% from the December 15th total of 2,400 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is presently 0.4 days.
View Cipher Pharmaceuticals' Short Interest.
When is Cipher Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 15th 2023.
View our CPHRF earnings forecast.

How were Cipher Pharmaceuticals' earnings last quarter?: Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) announced its quarterly earnings data on Thursday, May, 5th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The firm earned $9.10 million during the quarter, compared to analysts' expectations of $10.87 million.
What is Cipher Pharmaceuticals' stock symbol?: Cipher Pharmaceuticals trades on the OTCMKTS under the ticker symbol "CPHRF."
How do I buy shares of Cipher Pharmaceuticals?: Shares of CPHRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cipher Pharmaceuticals' stock price today?: One share of CPHRF stock can currently be purchased for approximately $2.56.
How can I contact Cipher Pharmaceuticals?: Cipher Pharmaceuticals' mailing address is 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada. The official website for the company is www.cipherpharma.com. The company can be reached via phone at (905) 602-5840.

This page (OTCMKTS:CPHRF) was last updated on 2/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial